Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say

M&A — Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say  STAT

Read the original at M&A ↗

Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. November 13, 2026.